Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Acquisitions (2023)

Historic Acquisitions for Perspective Therapeutics (CATX) over the last 1 years, with Q1 2023 value amounting to $2.7 million.

  • Perspective Therapeutics' Acquisitions changed N/A to $2.7 million in Q1 2023 from the same period last year, while for Dec 2023 it was $2.7 million, marking a year-over-year change of. This contributed to the annual value of $2.7 million for FY2023, which is N/A changed from last year.
  • Perspective Therapeutics' Acquisitions amounted to $2.7 million in Q1 2023.
  • Over the past 5 years, Perspective Therapeutics' Acquisitions peaked at $2.7 million during Q1 2023, and registered a low of $2.7 million during Q1 2023.